A single-center, open-label, randomized, multiple-dose, 3-treatment, 3-way crossover study to study three up-titration regimens of ponesimod in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 17 Nov 2015
At a glance
- Drugs Ponesimod (Primary)
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- 17 Nov 2015 New trial record